February 2001
Joe Weider's Muscle & Fitness;Feb2001, Vol. 62 Issue 2, p40
Deals with yohimbine, an alkaloid found in the bark of a West African evergreen tree, which has been approved by the United States Food and Drug Administration to treat erectile dysfunction. Objection from the American Urological Association officials on yohimbine; Emergence of concerns about yohimbine's side effects.


Related Articles

  • Effects of yohimbine on sexual experiences and nocturnal penile tumescence and rigidity in... Mann, Klaus; Klingler, Thomas // Archives of Sexual Behavior;Feb1996, Vol. 25 Issue 1, p1 

    Reports on a study concerning the effects of the alpha2-antagonist yohimbine in erectile dysfunction. Classification of patients into organic and nonorganic subgroups; Double-blind placebo-controlled design; Assessment of the effects of yohimbine on sexual experiences and nocturnal penile...

  • Oral yohimbine is effective and relatively safe for men with erectile dysfunction.  // Modern Medicine;Apr98, Vol. 66 Issue 4, p50 

    Presents an abstract of the article `Yohimbine for Erectile Dysfunction: A Systemic Review and Meta-analysis of Randomized Clinical Trials,' by E. Ernst, M.H. Pittler from `Journal of Urology' dated February 1998.

  • Yohimbe tree bark: Herbal Viagra better gotten by Rx.  // Environmental Nutrition;Feb99, Vol. 22 Issue 2, p8 

    Reports on the effectiveness of the yohimbe, derived from the bark of the West African tree Pausinystalia yohimbe, in treating impotence. Increase of sexual drive in rats; Increase of blood flow to the penis; Sale of isolated compound yohimbine as a prescription drug under the brand names Yocon...

  • Double-blind, placebo-controlled safety and efficacy trial with yohimbine hydrochloride in the treatment of nonorganic erectile dysfunction. Vogt, H.-J.; Brandl, P.; Kockott, G.; Schmitz, J.R.; Wiegand, M.H.; Schadrack, J.; Gierend, M. // International Journal of Impotence Research;1997, Vol. 9 Issue 3, p155 

    This double-blind, placebo-controlled clinical trial of yohimbine hydrochloride included 86 patients with erectile dysfunction and without clearly detectable organic or psychologic causes. The patient group fulfilled all entry criteria; 85 of these could be considered for the Safety respectively...

  • Treatment of erectile impotence.  // British Medical Journal;5/29/1976, Vol. 1 Issue 6021, p1298 

    Presents the treatment of erectile impotence in the United States. Variety of somatic processes; Effects of ageing; Increase incidence of erectile impotence.

  • Rebuilding the male machine. Cowley, Geoffrey; Rogers, Adam // Newsweek;11/17/1997, Vol. 130 Issue 20, p67 

    Focuses on the findings of research into the mechanics of male sex organs and the treatment of sexual impotence. Advances in understanding since the 1970s; Mechanism of a male erection; Diseases that can adversely affect male sexual function; Treatments that are available in late 1997. INSET:...

  • yohimbine. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p813 

    A definition of the term "yohimbine" is presented. It refers to a naturally occurring alkaloid that increases the flow of the blood to the peripheries of the body and dilates the pupil of the eye. Yohimbine has aphrodisiac properties and has been used to treat impotence. However, newer and more...

  • A pill to treat impotence? Gorman, Christine // Time International (South Pacific Edition);5/20/96, Issue 21, p62 

    Presents information on studies which suggest that a pill called sildenafil, might aid in the treatment of impotency in man. Other treatments available for impotence; Tests conducted on pill; What preliminary results show; Effectiveness of the pill in less than an hour; How drug can aid in the...

  • Yohimbine Depresses Excitatory Transmission in BNST and Impairs Extinction of Cocaine Place Preference Through Orexin-Dependent, Norepinephrine-Independent Processes. Conrad, Kelly L; Davis, Adeola R; Silberman, Yuval; Sheffler, Douglas J; Shields, Angela D; Saleh, Sam A; Sen, Namita; Matthies, Heinrich J G; Javitch, Jonathan A; Lindsley, Craig W; Winder, Danny G // Neuropsychopharmacology;May2013, Vol. 38 Issue 6, p1140 

    A correction to the article "Yohimbine Depresses Excitatory Transmission in BNST and Impairs Extinction of Cocaine Place Preference Through Orexin-Dependent, Norepinephrine-Independent Processes" by Namita Sen, Sam A. Saleh and colleagues that was published in the May 23, 2012 issue is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics